Steward Partners Investment Advisory’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Steward Partners Investment Advisory’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-70	Closed	-$3K	–	3478
2022 Q3	$3K	Buy	70 +50	+250%	+$3.23K	﹤0.01%	2985
2022 Q2	$1K	Buy	+20	New	+$1.46K	﹤0.01%	3204
2019 Q4	–	Sell	-50	Closed	-$2K	–	2787
2019 Q3	$2K	Hold	50	–	–	﹤0.01%	2471
2019 Q2	$2K	Buy	+50	New	+$2.33K	﹤0.01%	2481
2018 Q4	–	Sell	-50	Closed	-$3K	–	2313
2018 Q3	$3K	Hold	50	–	–	﹤0.01%	2312
2018 Q2	$2K	Sell	50 -25	-33%	-$1.03K	﹤0.01%	2280
2018 Q1	$2K	Sell	75 -330	-81%	-$12.9K	﹤0.01%	2063
2017 Q4	$17K	Sell	405 -320	-44%	-$15K	﹤0.01%	1194
2017 Q3	$37K	Buy	+725	New	+$40.4K	﹤0.01%	776

Other funds holding SYNH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Steward Partners Investment Advisory's SYNH Position: Q4 2022 in Review

Steward Partners Investment Advisory sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q4 2022, closing a stake of 70 shares — an estimated $3K sold.

Steward Partners Investment Advisory first reported a position in SYNH in Q3 2017 and held it in 9 quarters. The position peaked at $37K in Q3 2017. 307 funds tracked by Wall St. Rank hold SYNH as of Q4 2022.

Steward Partners Investment Advisory reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Steward Partners Investment Advisory sold 70 Syneos Health, Inc. Class A Common Stock shares in Q4 2022, an estimated $3K.
Steward Partners Investment Advisory first reported a position in Syneos Health, Inc. Class A Common Stock in Q3 2017 and held it in 9 quarters.
Steward Partners Investment Advisory's Syneos Health, Inc. Class A Common Stock position peaked at $37K in Q3 2017.
307 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q4 2022.

Based on Steward Partners Investment Advisory's 13F filing for Q4 2022, filed 15 Feb 2023.